Waters (WAT) Stock Price, News & Analysis

+14.10 (+4.71%)
(As of 04/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
561,555 shs
Average Volume
347,627 shs
Market Capitalization
$18.58 billion
P/E Ratio
Dividend Yield
Price Target

Waters MarketRank™ Stock Analysis

Analyst Rating
1.88 Rating Score
4.7% Downside
$298.67 Price Target
Short Interest
6.42% of Float Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.18mentions of Waters in the last 14 days
Based on 43 Articles This Week
Insider Trading
Selling Shares
$177,770 Sold Last Quarter
Proj. Earnings Growth
From $11.89 to $13.12 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.73 out of 5 stars

Medical Sector

419th out of 909 stocks

Analytical Instruments Industry

16th out of 27 stocks

WAT stock logo

About Waters Stock (NYSE:WAT)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

WAT Stock Price History

WAT Stock News Headlines

As a Mississippi town reels from a devastating tornado, a displaced family finds its way home
The town of Rolling Fork, Mississippi, has struggled to rebuild after a devastating tornado struck last year
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Waters (NYSE:WAT) Shares Gap Down to $304.18
See More Headlines
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Analytical instruments
Life Sciences Tools & Services
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
8 Analysts


Net Income
$642.23 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.96 billion
Cash Flow
$15.28 per share
Book Value
$19.45 per share


Free Float
Market Cap
$18.58 billion

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Udit Batra Ph.D. (Age 53)
    President, CEO & Director
    Comp: $1.17M
  • Mr. Amol Chaubal (Age 47)
    Senior VP & CFO
    Comp: $635.66k
  • Ms. Jianqing Y. Bennett (Age 54)
    Senior Vice President of TA Instruments Division & Waters Clinical Business Unit
    Comp: $621.09k
  • Mr. Christos Ross
    Senior VP of Global Operations & Interim Senior VP of the Waters Division
  • Caspar Tudor
    Director of Investor Relations
  • Ms. Keeley A. Aleman (Age 47)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $897.33k
  • Ms. Kristen Garvey
    Vice President of Corporate Communications
  • Mr. Patrick Conway
    Interim Vice President of Human Resources
  • Dr. Daniel Rush Ph.D.
    Senior Vice President of Strategy & Transformation
  • John Lynch

WAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Waters stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 1 sell rating and 7 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" WAT shares.
View WAT analyst ratings
or view top-rated stocks.

What is Waters' stock price target for 2024?

8 Wall Street research analysts have issued 1 year target prices for Waters' stock. Their WAT share price targets range from $250.00 to $340.00. On average, they predict the company's stock price to reach $298.67 in the next twelve months. This suggests that the stock has a possible downside of 4.7%.
View analysts price targets for WAT
or view top-rated stocks among Wall Street analysts.

How have WAT shares performed in 2024?

Waters' stock was trading at $329.23 at the beginning of the year. Since then, WAT shares have decreased by 4.8% and is now trading at $313.3350.
View the best growth stocks for 2024 here

When is Waters' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our WAT earnings forecast

How can I listen to Waters' earnings call?

Waters will be holding an earnings conference call on Tuesday, May 7th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) issued its quarterly earnings data on Tuesday, February, 6th. The medical instruments supplier reported $3.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.56 by $0.06. The medical instruments supplier had revenue of $819.50 million for the quarter, compared to analysts' expectations of $815.50 million. Waters had a net margin of 21.72% and a trailing twelve-month return on equity of 81.30%. Waters's revenue was down 4.5% compared to the same quarter last year. During the same period in the prior year, the company posted $3.84 EPS.
Read the conference call transcript

What guidance has Waters issued on next quarter's earnings?

Waters issued an update on its FY24 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of $11.75-12.05 for the period, compared to the consensus estimate of $11.94.

What is Udit Batra's approval rating as Waters' CEO?

13 employees have rated Waters Chief Executive Officer Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among the company's employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), RTX (RTX), CVS Health (CVS), Home Depot (HD), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

Who are Waters' major shareholders?

Waters' stock is owned by a variety of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.24%), Raymond James & Associates (0.17%), Progressive Investment Management Corp (0.04%), Lawson Kroeker Investment Management Inc. NE (0.03%), Amalgamated Bank (0.02%) and State of Alaska Department of Revenue (0.02%). Insiders that own company stock include Christopher A Kuebler, Edward Conard, Linda Baddour, Mark P Vergnano, Michael J Berendt and Thomas P Salice.
View institutional ownership trends

How do I buy shares of Waters?

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Waters have any subsidiaries?
The following companies are subsidiares of Waters: Analytical Products Group Inc., Andrew Alliance, Andrew Alliance S.A, Andrew Alliance SA (Switzerland), Andrew Alliance SASU (France), Anter Corporation, Baehr Thermoanalyse GmbH, Blue Reference Inc., Calorimetry Sciences Corporation, ElectroForce, Environmental Resource Associates Inc. (Colorado), Environmental Resources Associates, Integrated Software Solutions, Integrated Software Solutions Limited (UK), Integrated Software Solutions USA LLC, MPE Orbur Group Ltd. (UK), Manchester International Limited (Cayman), Melbourne International Limited (Cayman), Micromass Holdings Ltd. (UK), Micromass Ltd. (UK), Micromass UK Ltd. (UK), Midland Precision Equipment Co. Ltd. (UK), Milford International Limited (Cayman), Nihon Waters K.K. (Japan), NuGenesis Technologies Corporation, Rubotherm, TA Instruments Japan Inc. (Japan), TA Instruments-Waters LLC (Delaware), Thar Instruments Inc, Thermometric AB, VICAM, VTI Corporation, Waters (TC) Israel Ltd. (Israel), Waters A/S (Denmark), Waters AG (Switzerland), Waters Analytical Instruments Sdn Bhd (Malaysia), Waters Asia Limited (Delaware), Waters Australia PTY LTD. (Australia), Waters Celtic Holdings Ltd. (Ireland), Waters China Ltd. (Hong Kong), Waters Chromatography BV (Netherlands), Waters Chromatography Europe BV (Netherlands), Waters Chromatography Ireland Ltd. (Ireland), Waters Corporation (Delaware), Waters Cromatografia SA (Spain), Waters European Investments LLC (Cayman) (2), Waters Ges.MBH (Austria), Waters Global International Limited (Cayman) (1), Waters Global Limited (UK) (1), Waters GmbH (Germany), Waters Holdings LLC (Delaware), Waters India Pvt. Ltd., Waters Kft (Hungary), Waters Korea Limited (Korea), Waters Limited (Canada), Waters Limited (UK), Waters Luxembourg SARL (Luxembourg), Waters NV (Belgium), Waters O.O.O. (Russia) (1), Waters Pacific Pte Ltd. (Singapore), Waters Research Center Kft (Hungary), Waters Romania Srl, Waters SA de CV (Mexico), Waters SAS (France), Waters Sp.Zo.o (Poland), Waters SpA (Italy), Waters Sverige AB (Sweden), Waters Tech. LC-MS Unipessol Lda (Portugal), Waters Technologies (Beijing) Co. Ltd (China), Waters Technologies (Shanghai) Ltd (China), Waters Technologies Corporation (Delaware), Waters Technologies International Limited (Cayman) (1), Waters Technologies Ireland Ltd. (Ireland), and Waters Technologies do Brasil Ltda (Brazil).
Read More
This page (NYSE:WAT) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners